Grove Bank & Trust Astrazeneca PLC Transaction History
Grove Bank & Trust
- $876 Million
- Q4 2025
A detailed history of Grove Bank & Trust transactions in Astrazeneca PLC stock. As of the latest transaction made, Grove Bank & Trust holds 11,570 shares of AZN stock, worth $1.03 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
11,570
Previous 11,475
0.83%
Holding current value
$1.03 Million
Previous $880,000
17.5%
% of portfolio
0.12%
Previous 0.1%
Shares
29 transactions
Others Institutions Holding AZN
# of Institutions
1,544Shares Held
503MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...